Skip to main content

Evidence for pharmacodynamic differences between cardiac glycosides of different polarities

  • Conference paper
Cardiac Glycosides 1785–1985
  • 97 Accesses

Summary

We compared the effects of digitoxin (lipophilic) and ouabain (hydrophilic) in rats under pentobarbital anaesthaesia on inotropy (dp/dt) and atrioventricular conduction (PR-interval). Doses of the glycosides which produced a 40–50% increase in dp/dt produced a significantly greater prolongation of the PR interval with ouabain than with digitoxin. Neither vagotomy nor atropine administration abolished this difference, but the difference could be eliminated by pre-treatment with propranolol. We concluded that the smaller effect of digitoxin on atrioventricular (AV) conduction was due to a central sympathomimetic effect which does not occur with ouabain.

A respiratory depressant effect of digitalis has been reported in humans. We therefore compared the effect of acetyldigitoxin (relatively lipophilic) to that of digoxin (relatively hydrophilic) on the hyper-ventilatory response to inhaled CO2 in healthy volunteers. We found that at mean steady state levels of 12.5 ± 1.07 ng/ml (digitoxin) and 0.87 ± 0.2 ng/ml (digoxin), digitoxin appeared to stimulate ventilation as measured by minute ventilation and oxygen consumption and digoxin appeared to depress ventilation. These observations appear to be consistent with a sympathomimetic effect of the acetyldigitoxin as observed in our animal experiments. It might also be consistent with a greater vagomimetic effect with digoxin as suggested by Runge in 1977. Further research is currently being done to elucidate the mechanisms of the observed differences.

These findings suggest that when cardiac glycosides are used for supraventricular tachyarrhythmias a more hydrophilic cardiac glycoside might be indicated. If on the other hand digitalis is used for its positive inotropic effect, the use of a lipophilic cardiac glycoside might reduce the risk of atrioventricular block. It also seems that if digitalis is used in patients with respiratory impairment, a more lipophilic cardiac glycoside might be preferable.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alken R, Belz G (1984) A comparative dose-effect study with cardiac glycosides assessing cardiac and extracardiac responses in normal subjects. J Cardiovasc Pharmacol 6: 634–640

    Article  PubMed  CAS  Google Scholar 

  2. Aravanis C, Luisada A (1958) Clinical comparison of six digitalis preparations by the parenteral route. Am J Cardiol 74: 706–716

    Article  Google Scholar 

  3. Batterman RC et al (1950) The comparative value of gitalin and other digitalis preparations. Fed Proc 9: 256–261

    Google Scholar 

  4. Eicha LW, Taube H (1943) A comparison of the actions of four cardiac glycosides on a patient with congestive heart failure. Am Heart J 26: 631–644

    Article  Google Scholar 

  5. Hoffman BF, Bigger JT (1980) In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 6th Edition. MacMillan, New York, pp 748–749

    Google Scholar 

  6. Joubert P, van der Meer L (1979) A specific cardiac glycoside for cardiac failure and another for atrial fibrillation. S Afr Med J 56: 1040–1042

    PubMed  CAS  Google Scholar 

  7. Joubert PH et al (1985) Effects of digoxin and acetyl-digitoxin on basal and CO2-stimulated ventilation. Eur J Clin Pharmacol 28: 155–158

    Article  PubMed  CAS  Google Scholar 

  8. Riggert H, Schwab M (1955) Der Einfluß von Digitoxin auf die Atmung des herzgesunden Menschen. Z ges Exp Med 125: 80–92

    Article  PubMed  CAS  Google Scholar 

  9. Runge T (1977) Clinical implications of differences in pharmacodynamic action of polar and non-polar cardiac glycosides. Am Heart J 93: 248–255

    Article  PubMed  CAS  Google Scholar 

  10. Runge T et al (1975) Pharmacodynamic distinctions between ouabain, digoxin and digitoxin. Arch Int Pharmacodyn 214: 31–45

    PubMed  CAS  Google Scholar 

  11. Scott Cook L et al (1982) Adrenergic and cholinergic mechanisms in digitalis inotropy. J Pharm Exp Therap 223: 761–765

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Joubert, P.H. (1986). Evidence for pharmacodynamic differences between cardiac glycosides of different polarities. In: Erdmann, E., Greef, K., Skou, J.C. (eds) Cardiac Glycosides 1785–1985. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-11292-2_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-11292-2_28

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-662-11294-6

  • Online ISBN: 978-3-662-11292-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics